University of Queensland researchers have discovered immunotherapy, when used to treat people with advanced cancers, also ...
Upon Opdualag’s approval in 2022 as a first-in-class cancer immunotherapy, Bristol Myers Squibb was anxious to explore its potential in a variety of indications. | Bristol Myers Squibb is striking out ...
A new pilot cohort study linked immune checkpoint inhibitors with a reduction in actinic keratoses in patients undergoing ...
Intra-ImmuSG seeks to develop a safer and more effective cancer therapy via a combination of a targeted therapy and immunotherapy.
New research highlights the potential of the novel diagnostic tool iFRET to determine immunotherapy outcomes in stage 2 ...
The Micro Immune Response On chip (MIRO) allows tumours and their environment to be replicated in order to understand their ...
News Medical on MSN1d
Immunotherapy reduces sunspots and skin cancer by 65%University of Queensland researchers have discovered immunotherapy, when used to treat people with advanced cancers, also helps reduce sunspots and skin cancers by at least 65 per cent.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback